WVE

15.54

4.90% -0.80

Dopo l'orario di chiusura: 15.66 0.12 +0.77%

Wave Life Sciences Ltd (WVE)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché WVE Giù? Forum Previsione

Precedente Chiudi:

$16.34

Aprire:

$16.35

Volume 24 ore:

3.54M

Relative Volume:

0.59

Capitalizzazione di mercato:

$2.89B

Reddito:

$93.95M

Utile/perdita netta:

$-129.87M

Rapporto P/E:

-17.27

EPS:

-0.9

Flusso di cassa netto:

$-202.88M

1 W Prestazione:

-7.22%

1M Prestazione:

+118.57%

6M Prestazione:

+125.22%

1 anno Prestazione:

+18.72%

Intervallo 1D:

$15.23

$16.64

Intervallo di 1 settimana:

$15.23

$17.77

Portata 52W:

$5.28

$21.73

Wave Life Sciences Ltd Stock (WVE) Company Profile

Nome

Wave Life Sciences Ltd

Settore

Healthcare (1134)

Industria

Biotechnology (634)

Telefono

617-949-2900

Indirizzo

7 STRAITS VIEW, SINGAPORE

Dipendente

288

Cinguettio

@WAVELifeSci

Prossima data di guadagno

2025-03-04

Ultimi documenti SEC

WVE's Discussions on Twitter

Confronta WVE con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
WVE Wave Life Sciences Ltd	15.54	3.04B	93.95M	-129.87M	-202.88M	-0.90
VRTX Vertex Pharmaceuticals Inc	447.38	114.05B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	748.71	78.80B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	396.04	51.80B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	847.05	53.08B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	166.55	42.33B	447.02M	-1.18B	-906.14M	-6.1812

Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-12-12	Reiterato	Wedbush	Outperform
2025-12-09	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2025-10-20	Iniziato	Wells Fargo	Overweight
2025-08-04	Iniziato	Canaccord Genuity	Buy
2025-07-28	Iniziato	Oppenheimer	Outperform
2025-07-16	Iniziato	Citigroup	Buy
2025-06-11	Ripresa	Raymond James	Outperform
2025-04-29	Iniziato	Cantor Fitzgerald	Overweight
2025-04-08	Iniziato	Wedbush	Outperform
2025-02-25	Iniziato	Jefferies	Buy
2024-10-16	Aggiornamento	Raymond James	Outperform → Strong Buy
2024-09-27	Ripresa	JP Morgan	Overweight
2024-09-19	Iniziato	B. Riley Securities	Buy
2024-09-09	Iniziato	JP Morgan	Overweight
2024-05-15	Iniziato	Wells Fargo	Overweight
2023-12-19	Aggiornamento	Leerink Partners	Market Perform → Outperform
2023-07-05	Iniziato	Raymond James	Outperform
2023-05-24	Downgrade	Jefferies	Buy → Hold
2020-12-15	Ripresa	H.C. Wainwright	Buy
2020-10-23	Iniziato	RBC Capital Mkts	Sector Perform
2019-12-31	Downgrade	SVB Leerink	Outperform → Mkt Perform
2019-11-01	Iniziato	Guggenheim	Buy
2019-07-15	Iniziato	Cowen	Market Perform
2019-04-17	Reiterato	H.C. Wainwright	Buy
2018-08-07	Iniziato	Stifel	Buy
2018-07-23	Iniziato	H.C. Wainwright	Buy
2018-03-19	Reiterato	Mizuho	Buy
2017-02-15	Iniziato	H.C. Wainwright	Buy
2016-11-10	Ripresa	Leerink Partners	Outperform
2015-12-07	Iniziato	JMP Securities	Mkt Outperform
2015-12-07	Iniziato	Jefferies	Buy
2015-12-07	Iniziato	Leerink Partners	Outperform
2015-12-07	Iniziato	Sun Trust Rbsn Humphrey	Buy

Mostra tutto

Wave Life Sciences Ltd Borsa (WVE) Ultime notizie

02:57 AM

Wave Life Sciences (WVE) Stock News Today (Dec. 18, 2025): Why Shares Are Sliding, New Analyst Targets, and the Next Catalysts After WVE-007 Obesity Data - ts2.tech

02:57 AM

12:38 PM

WAVE Life Sciences (NASDAQ:WVE) Shares Down 4.3%Here's Why - MarketBeat

12:38 PM

Dec 17, 2025

CEO Moves: Is Wave Life Sciences Ltd stock supported by innovation pipeline2025 Market Trends & Step-by-Step Trade Execution Guides - moha.gov.vn

Dec 17, 2025

Wave Life Sciences (WVE) Is Down 19.2% After $350 Million Equity Raise On Obesity DataWhat's Changed - simplywall.st

Dec 17, 2025

Wave Life Sciences drops after trial data for GSK-partnered RNA-editing therapy - MSN

Dec 17, 2025

Share Offerings Prompt Huge Insider Buying in These 3 Biotechs - AOL.com

Dec 17, 2025

United StatesMintz Advises On Wave Life Sciences $402.5 Million Public Offering - Mondaq

Dec 17, 2025

Dec 16, 2025

Oppenheimer Maintains Wave Life Sciences (WVE) Outperform Recommendation - Nasdaq

Dec 16, 2025

Oppenheimer raises WAVE Life Sciences stock price target to $32 on WVE-007 data By Investing.com - Investing.com South Africa

Dec 16, 2025

Best Biotech Stocks To Keep An Eye OnDecember 8th - MarketBeat

Dec 16, 2025

WAVE Life Sciences (NASDAQ:WVE) Shares Gap Up Following Insider Buying Activity - MarketBeat

Dec 16, 2025

Oppenheimer Raises Price Target for WAVE Life Sciences (WVE) | WVE Stock News - GuruFocus

Dec 16, 2025

Wave Life Sciences (WVE) Stock News Today: Oppenheimer Lifts Target to $32 as WVE-007 Obesity Data Fuels Volatility - ts2.tech

Dec 16, 2025

Wave Life (WVE) shares nearly triple on encouraging obesity drug trial - MSN

Dec 16, 2025

Subdued Growth No Barrier To Wave Life Sciences Ltd. (NASDAQ:WVE) With Shares Advancing 128% - simplywall.st

Dec 16, 2025

Oppenheimer raises WAVE Life Sciences stock price target to $32 on WVE-007 data - Investing.com India

Dec 16, 2025

Dec 15, 2025

Obesity data, Kymera and FDA sentiment survey results — a BioCentury podcast - BioCentury

Dec 15, 2025

WAVE Life Sciences (NASDAQ:WVE) Major Shareholder Purchases 1,470,000 Shares - MarketBeat

Dec 15, 2025

Wave Life Sciences’ Obesity Drug Draws $10 Billion Expectations - Finimize

Dec 15, 2025

Wave Life Sciences' Obesity Drug Shows Promise for Long-Term Growth, Truist Says - marketscreener.com

Dec 15, 2025

Truist Securities Maintains Wave Life Sciences (WVE) Buy Recommendation - Nasdaq

Dec 15, 2025

Truist Securities Elevates WAVE Life Sciences (WVE) Price Target to $50 | WVE Stock News - GuruFocus

Dec 15, 2025

WAVE Life Sciences stock price target raised to $50 from $36 at Truist - Investing.com India

Dec 15, 2025

Truist Raises Price Target on Wave Life Sciences to $50 From $36, Keeps Buy Rating - marketscreener.com

Dec 15, 2025

Why Did Wave Life Sciences Surge 147%? - Forbes

Dec 15, 2025

Dec 14, 2025

Wave Life (WVE) Shares Nearly Triple on Encouraging Obesity Drug Trial - Insider Monkey

Dec 14, 2025

Medical Stocks To Watch TodayDecember 8th - MarketBeat

Dec 14, 2025

Dec 13, 2025